Revolution Medicines Inc. (RVMD)
39.90
0.07 (0.18%)
At close: Jan 15, 2025, 12:45 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -7.44 | -7.72 | -10.19 | -24.38 | -35.77 | -25.22 | -33.86 |
| PS Ratio | 280.24 | 54.28 | 62.35 | 61.34 | 34.07 | 52.27 | n/a |
| PB Ratio | 1.78 | 2.80 | 3.04 | 5.55 | 11.18 | 10.91 | 232.64 |
| P/FCF Ratio | -9.06 | -8.16 | -11.92 | -25.6 | -32.66 | -3.69K | -39.44 |
| P/OCF Ratio | -9.26 | -8.56 | -12.45 | -26.35 | -34.37 | 868.98 | -41.91 |
| OCF/S Ratio | -30.27 | -6.34 | -5.01 | -2.33 | -0.99 | 0.06 | n/a |
| Debt / Equity Ratio | 0.05 | 0.09 | 0.11 | 0.07 | 0.00 | 0.00 | n/a |
| Quick Ratio | 13.06 | 10.65 | 31.15 | 9.63 | 3.11 | 2.58 | 1.24 |
| Current Ratio | 13.06 | 10.65 | 30.48 | 9.63 | 3.11 | 2.80 | 1.24 |
| Asset Turnover | 0.01 | 0.04 | 0.04 | 0.08 | 0.23 | 0.12 | n/a |
| Interest Coverage | -1.61K | n/a | -15.67K | -1.56K | -510.57 | -347.66 | -302.22 |
| Return on Equity (ROE) | -0.24 | -0.36 | -0.3 | -0.23 | -0.31 | -0.43 | -6.87 |
| Return on Assets (ROA) | -0.21 | -0.31 | -0.24 | -0.19 | -0.22 | -0.24 | -2.06 |
| Return on Capital (ROIC) | -0.25 | -0.34 | -0.26 | -0.21 | -0.3 | -0.29 | -4.16 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 72.71% | 75.05% | -207.68% | -83.36% | 91.25% | n/a |
| Net Profit Margin | -3.77K% | -702.95% | -611.67% | -251.63% | -95.25% | -207.24% | n/a |
| Pretax Profit Margin | -3.80K% | -704.14% | -636.58% | -252.5% | -103.99% | -207.24% | n/a |
| Operating Profit Margin | -4.21K% | -730.01% | -639.7% | -257.54% | -108.15% | -200% | n/a |
| FCF Margin | -3.09K% | -664.83% | -522.99% | -239.62% | -104.32% | -1.42% | n/a |
| EBITDA Margin | -3.72K% | -676.85% | -611.59% | -237.1% | -97.1% | -197.91% | n/a |